joanne ern chi soh, nadiah abu, ismail sagap, luqman mazlan,azyani yahaya,muaatamarulain mustangin, tze sean khoo, sazuita saidin, muhiddin ishak, nurul syakima ab mutalib and rahman jamal.  (2019).  validation of immunogenic pasd1 peptidesagainst hla-a*24:02 colorectal cancer.  - immunotherapy.  1205-1219. 

nurul-syakima ab mutalib, ryia illani mohd yunos, najwa farhah mohd yusof, muhiddin ishak, sazuita saidin, isa mohamed rose, luqman mazlan, ismail sagap, rahman jamal.  (2019).  the landscape of recurrent noncoding mutations in colorectal cancers.  - gut.  A36. 

muhiddin ishak, najwa farhah mohd yusof, sazuita saidin, isa mohamed rose, luqman mazlan, ismail sagap, rahman jamal, nadiah abu, nurul syakima ab mutalib..  (2019).  methylation profiles of phantom 5 enhancer and open chromatin in colorectal cancers.  - gut.  A35-A36. 

shafina nadiawati abdul, nurul syakima ab mutalib, khor s. sean, saiful e. syafruddin, muhiddin ishak, ismail sagap, luqman mazlan, isa m. rose, nadiah abu, norfilza m. mokhtar and rahman jamal.  (2017).  molecular characterization of somatic alterations in dukes b and c colorectal cancers by targeted sequencing.  - frontiers in pharmacology.  1-19. 

noraidatulakma abdullah, nor azian abdul murad, ezanee azlina mohd haniff, saiful effendi syafruddin, john attia, christopher oldmeadow, mohd arman kamaruddin, nazihah abd jalal, norliza ismail, muhiddin ishak, rahman jamal, rodney j. scott, elizabeth gh.  (2017).  predicting type 2 diabetes using genetic and environmental risk factors in a multi-ethnic malaysian cohort.  - public health.  31-38. 

n abdullah, na abdul murad, j attia, c oldmeadow, ea mohd haniff, se syafruddin, n abd jalal, n ismail, m ishak, r jamal, rj scott and eg holliday.  (2015).  characterizing the genetic risk for type 2 diabetes in a malaysian multi-ethnic cohort.  - diabetic medicine.  1377-1384.